On-site Basic Health Screening and Brief Health Counseling of Chronic Medical Conditions for Veterans in Methadone Maintenance Treatment.
BACKGROUND: In order to improve the delivery of health services for chronic medical conditions in our methadone clinic, we added an onsite health screening and brief health counseling to the treatment plans for patients receiving methadone maintenance treatment at the Atlanta Veterans Affairs Medical Center (VAMC). We then conducted a follow up retrospective chart review to assess whether this intervention improved health outcome for those patients. METHODS: We reviewed the charts of one hundred and two patients who received treatment at Atlanta VAMC methadone clinic between 2002 and 2008. We sought to determine whether our increased health education and screening intervention was associated with improved: 1) Improved drug addiction outcome (as measured by comparing percentage of opiate and cocaine positive drug screens from admission to most recent). 2) Basic health screening, (as measured by the patient's compliance with primary care physicians (PCP) appointments and current smoking status). 3) Management of co-occurring medical conditions (as measured by levels of LDL cholesterol, hemoglobin A1c, and systolic blood pressure (SBP). 4) Presence of QTc prolongation (difference in QTc between baseline and most recent EKG). RESULTS: Illicit drug use (opiate and cocaine) markedly decreased in patients overall. The effect was more robust for those successfully "retained" (n=55, p<0.0001) in treatment, compared to those who "dropped out" (n=40, p=0.05) of treatment. Compliance with PCP appointments was high (82% and 88% before and after the onsite intervention, respectively) for "retained" patients. LDL cholesterol level was within normal range for all patients. A1c improved by 40% after the onsite intervention as reflected by the decreased percentage of patients with A1c > 7 % from before to after the intervention (90% vs. 50%, p=0.05). However, the prevalence of uncontrolled hypertension did not significantly improve after the onsite intervention (38% vs. 28%, p=0.34). As might be expected with MMT, the prevalence of QTc prolongation actually increased from 399 m sec. (+/- 92) to 439 msec. (+/- 22) after the onsite intervention (p=0.003). CONCLUSIONS: Our retrospective study supports the previous literature that methadone maintenance therapy is effective in reducing illicit drug use. Although patients with history of heroin dependence and in methadone maintenance treatment are at increased risk for chronic medical conditions like hepatitis C and diabetes, there are minimal federal guidelines for medical care, except than a physical exam upon admission, and basic screening for some infectious diseases e.g. HIV and Hepatitis C for those patients. Our study demonstrated the need for and potential benefit of enhancing the delivery of health promotion services for chronic medical conditions in methadone maintained patients. Improving management of hepatitis C, diabetes, hypertension, and other related conditions, in this high risk, difficult-to-treat, and underserved population may reduce their morbidity and premature mortality.
Fareed
Ayman
A
Atlanta Veterans Administration Medical Center, Decatur, Georgia.
Musselman
Dominique
D
Byrd-Sellers
Johnita
J
Vayalapalli
Sreedevi
S
Casarella
Jennifer
J
Drexler
Karen
K
Phillips
Lawrence
L
Addiction. 2005 Jul;100(7):981-9
15955014
Hepatology. 2003 Dec;38(6):1384-92
14647049
Br Med J. 1973 Jun 9;2(5866):582-5
4713988
MMWR Morb Mortal Wkly Rep. 2003 Apr 11;52(14):303-4, 306-7
12731700
Addiction. 1998 Apr;93(4):515-32
9684390
J Gastroenterol. 2003;38(4):355-60
12743775
Arch Gen Psychiatry. 1976 Jun;33(6):709-20
779705
Arch Intern Med. 1994 May 23;154(10):1121-7
8185425
Am J Gastroenterol. 2003 Feb;98(2):438-41
12591065
Clin Infect Dis. 2003 May 15;36(10):1318-23
12746779
Ann Intern Med. 2009 Mar 17;150(6):387-95
19153406
Clin Infect Dis. 2005 May 15;40(10):1492-9
15844072
Gastroenterology. 2003 Dec;125(6):1695-704
14724822
Gastroenterology. 2004 Mar;126(3):840-8
14988838
J Hepatol. 2001 Aug;35(2):279-83
11580152
JAMA. 1965 Aug 23;193:646-50
14321530
J Psychiatr Pract. 2009 May;15(3):227-34
19461397
Mayo Clin Proc. 1993 Feb;68(2):170-82
8423698
Arch Gen Psychiatry. 1983 Jun;40(6):620-5
6847331
Prev Med. 2007 Apr;44(4):369-74
17291577
Metabolism. 1983 Dec;32(12):1163-5
6358781
Hepatology. 2005 Nov;42(5):987-1000
16250043
J Hepatol. 2008 Sep;49(3):429-40
18486982
J Natl Cancer Inst. 2000 Dec 6;92(23):1888-96
11106680
MMWR Morb Mortal Wkly Rep. 2008 Dec 5;57(48):1297-300
19052527
Liver Int. 2008 Feb;28(2):175-88
18251977
Am J Pathol. 2004 Nov;165(5):1499-508
15509521
Horm Metab Res. 1987 Sep;19(9):430-3
3319862
Ann Intern Med. 1993 Jul 1;119(1):23-7
8498759
Drug Alcohol Depend. 1998 Feb 1;49(3):217-23
9571386
HIV Med. 2006 Sep;7(6):389-96
16903984